ProShares UltraShort Nasdaq Biotechnology
BISNASDAQProSharesEquity
As of Oct 22, 2026 close
- Assets (AUM)
- $1.94M
- Expense ratio
- 0.95%
- Dividend yield
- 5.52%
- Holdings
- 6
- 52-week range
- $8.31$20.00
- Volume (live)
- -
- Avg. volume (3M)
- 9.50K
BIS ETF: ProShares UltraShort Nasdaq Biotechnology - Price, Holdings & Analysis
ProShares UltraShort Nasdaq Biotechnology Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $10.91 - $11.41 |
|---|---|
| 52-Week High | $20.00 |
| 52-Week Low | $8.31 |
| Open | $11.14 |
| Volume (last close) | 12.45K |
| Average Volume (3M) | 9.50K |
| 1 Day Change | +1.43% |
|---|---|
| 1 Month Change | −2.67% |
| 6 Month Change | −33.68% |
| YTD Change | +17.95% |
| 1 Year Change | −4.60% |
| 5 Year Change | −41.14% |
| 10 Year Change | −92.31% |
| Annual Dividend | $0.62 |
|---|---|
| Dividend Yield | 5.52% |
| Last Dividend Ex-Date | Sep 23, 2026 |
| Dividend Growth YoY | −48.63% |
| Assets (AUM) | $1.94M |
|---|---|
| Expense Ratio | 0.95% |
| Total Holdings | 6 |
| Inception Date | Apr 7, 2010 |
| 50-Day MA | $11.55 |
|---|---|
| 200-Day MA | $13.71 |
| RSI | 43.63 |
| Stochastic %K | 1.61 |
| Stochastic %D | 40.29 |
Source: Exchange price data and fund disclosures. Data as of Oct 22, 2026. Data sources and methodology
BIS at a Glance
ProShares UltraShort Nasdaq Biotechnology (BIS) is an equity ETF from ProShares, launched in April 2010. It manages $1.94M in assets and charges a 0.95% expense ratio, about $95 a year per $10,000 invested.
It holds 6 positions. The largest are Amgen Inc (AMGN, 8.14%), Gilead Sciences, Inc (GILD, 7.41%) and Vertex Pharmaceuticals Incorporated (VRTX, 7.21%). The top 10 holdings make up 48.0% of the fund.
It pays distributions yielding 5.52% at the Oct 22, 2026 close, $0.62 per share over the trailing 12 months. As of the Oct 22, 2026 close, the share price is down 4.6% over one year, down 41.1% over five years and down 92.3% over ten years (price change, excluding distributions).
Frequently Asked Questions About ProShares UltraShort Nasdaq Biotechnology
What is the current price of BIS?
The latest BIS price is $11.19 (Oct 22, 2026 close). The 52-week range is $8.30–$20.00. The share price is down 4.6% over the past year (price change, excluding distributions).
What is the expense ratio for BIS?
BIS's annual expense ratio is 0.95%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does BIS pay dividends?
Yes, BIS pays a 5.52% dividend yield (trailing 12 months, at the Oct 22, 2026 close). The most recent ex-dividend date was September 23, 2026. View full dividend history in the Dividends section.
What are the top holdings of BIS?
BIS's largest holdings are Amgen Inc (8.1%), Gilead Sciences, Inc (7.4%), Vertex Pharmaceuticals Incorporated (7.2%) (combined weight: 22.8%). The fund holds 6 total positions. View the complete portfolio breakdown in the Holdings section.
How does BIS compare to similar ETFs?
Compare BIS (0.95% expense ratio, $2M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.